Press Releases

Press Releases

Search by keywords:

187 Press Releases found

Memorial Sloan Kettering Establishes New Center for Molecular Imaging and Nanotechnology

Memorial Sloan Kettering has launched a collaborative translational research center that will unite researchers specializing in two rapidly growing fields: molecular imaging and nanotechnology.

  • Friday, April 25, 2014

Study Reveals Mechanisms Cancer Cells Use to Establish Metastatic Brain Tumors

New research from Memorial Sloan Kettering provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain.

  • Thursday, February 27, 2014

Memorial Sloan Kettering Appoints Pereira & O’Dell New York as Creative Agency of Record, Media Storm as Media Agency of Record

Memorial Sloan Kettering announced the appointment of Pereira & O’Dell in New York as its creative agency of record and Media Storm as its media agency of record.

  • Tuesday, February 25, 2014

Cell Therapy Shows Remarkable Ability to Eradicate Cancer in Clinical Study

The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.

  • Wednesday, February 19, 2014

Research Links Obesity to Poor Survival in Tongue Cancer Patients

A collaborative effort among cancer experts from Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College has yielded an interesting association: Obesity prior to diagnosis is associated with a five-fold increase in the risk of death from early-stage squamous cell carcinoma of the tongue.

  • Tuesday, February 4, 2014

Newly Engineered Monoclonal Antibody Shows Promise, Moves toward Clinical Testing

Memorial Sloan Kettering and Eureka Therapeutics recently entered into a licensing agreement with Novartis to develop a unique monoclonal antibody.

  • Tuesday, January 28, 2014

Memorial Sloan Kettering Cancer Center Shares $540 Million in New Funding From Ludwig Cancer Research

Memorial Sloan Kettering Cancer Center, along with five other elite academic institutions, will share an unprecedented total of $540 million in new financial support from Ludwig Cancer Research.

  • Monday, January 6, 2014

Foundation Medicine Launches FoundationOne™ Heme, Developed in Collaboration with Memorial Sloan Kettering Cancer Center

FoundationOne Heme was developed using technology, methods and computational algorithms developed by Foundation Medicine, combined with Memorial Sloan Kettering’s deep and vast expertise in clinical and laboratory research into hematologic malignancies.

  • Saturday, December 7, 2013

Accomplished Scientist and Entrepreneur Selected to Lead Tri-Institutional Therapeutics Discovery Institute

Michael A. Foley, PhD, has been selected to lead the Tri-Institutional Therapeutics Discovery Institute, Inc., a pioneering collaboration of Weill Cornell Medical College, The Rockefeller University and Memorial Sloan Kettering Cancer Center.

  • Thursday, December 5, 2013

Cancer Biologist Joan Massagué Named Director of the Sloan Kettering Institute

Renowned cancer biologist Joan Massagué, PhD, has been named Director of the Sloan Kettering Institute, one of the most dynamic and robust cancer research programs in the United States, and the research arm of Memorial Sloan Kettering Cancer Center.

  • Monday, November 25, 2013